West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT, a leading primary packaging solutions provider, have announced a partnership to combine the SCHOTT iQ® platform with West’s Ready Pack™ system.

The collaboration will initially launch by combining West components and SCHOTT’s adaptiQ® high-quality RTU glass vials and will expand to include other convenient, ready-to-use combinations of West and SCHOTT products, to be available on a small-quantity basis.

The companies made the announcement at the CPhI Worldwide conference, and shared plans to expand West’s Ready Pack system to include additional SCHOTT glass offerings— including more vial formats as well as ready-to-use cartridges (cartriQ™) and pre-fillable glass syringes (syriQ®). Further product launch plans will be shared at the Pharmapack meeting in early 2020.

West’s Ready Pack system consists of sterilized NovaPure^® stoppers, Flip-Off^® CCS seals and SCHOTT’s adaptiQ^® vials. Ready Pack components are provided ready-to-use, from stock, so they are prepared to ship when customers place their order. The combination of West and SCHOTT products is well-suited for Research and Development purposes or for small filling operations.   The Ready Pack system is also scalable, designed to support a smooth transition from early-stage pilot manufacture to larger commercial-scale operations. All Ready Pack components have been tested and proven fit-for-use. This is supported by comprehensive technical data reports, including container closure integrity data, to support manufacturers in their development.   West’s Ready Pack system is available to order via West’s online store.

SCHOTT’s adaptiQ^® vials were developed in cooperation with innovative and highly regarded machine suppliers. The vials will be available in various formats with different sterile packaging options such as the clip nest, cup nest and tray solution and can be processed on a wide range of existing and new fill and finish equipment. Nested processing of the vials ensures no glass-to-glass contact of the vials throughout the fill finish process including lyophilization.

Forthcoming combinations of the products within the Ready Pack and SCHOTT iQ^® platforms will extend to customizable configurations in order to meet various requirements, whether changing batch sizes or accommodating different container needs, especially for biologic drugs.  In the near future, West and SCHOTT look forward to growing this partnership through more combined high-quality product offerings leveraging the SCHOTT iQ^® portfolio as well as a range of West and Daikyo proprietary packaging components in response to the needs of global customers and ultimately, serving patients.